Therefore, the optimal combination of membrane-expressed proteins to target by molecular imaging seemed to consist of CD44v6, GLUT1, EGFR, HER2, and IGF1-R by which about 80% of invasive breast cancers are predicted to be detectable. Here, SLC2A1 is linked to invasive breast carcinoma.